517 related articles for article (PubMed ID: 19386702)
1. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
Geisbert TW; Geisbert JB; Leung A; Daddario-DiCaprio KM; Hensley LE; Grolla A; Feldmann H
J Virol; 2009 Jul; 83(14):7296-304. PubMed ID: 19386702
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
Front Immunol; 2021; 12():703986. PubMed ID: 34484200
[TBL] [Abstract][Full Text] [Related]
3. Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses.
Geisbert TW; Daddario-Dicaprio KM; Geisbert JB; Reed DS; Feldmann F; Grolla A; Ströher U; Fritz EA; Hensley LE; Jones SM; Feldmann H
Vaccine; 2008 Dec; 26(52):6894-900. PubMed ID: 18930776
[TBL] [Abstract][Full Text] [Related]
4. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.
Geisbert TW; Strong JE; Feldmann H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S91-7. PubMed ID: 26063223
[TBL] [Abstract][Full Text] [Related]
5. Ebola and Marburg virus vaccines.
Reynolds P; Marzi A
Virus Genes; 2017 Aug; 53(4):501-515. PubMed ID: 28447193
[TBL] [Abstract][Full Text] [Related]
6. Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges).
Dye JM; Warfield KL; Wells JB; Unfer RC; Shulenin S; Vu H; Nichols DK; Aman MJ; Bavari S
Viruses; 2016 Apr; 8(4):94. PubMed ID: 27070636
[TBL] [Abstract][Full Text] [Related]
7. Preexisting Immunity Does Not Prevent Efficacy of Vesicular Stomatitis Virus-Based Filovirus Vaccines in Nonhuman Primates.
Marzi A; Feldmann F; O'Donnell KL; Hanley PW; Messaoudi I; Feldmann H
J Infect Dis; 2023 Nov; 228(Suppl 7):S671-S676. PubMed ID: 37290042
[TBL] [Abstract][Full Text] [Related]
8. A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge.
Woolsey C; Cross RW; Agans KN; Borisevich V; Deer DJ; Geisbert JB; Gerardi C; Latham TE; Fenton KA; Egan MA; Eldridge JH; Geisbert TW; Matassov D
PLoS Negl Trop Dis; 2022 May; 16(5):e0010433. PubMed ID: 35622847
[TBL] [Abstract][Full Text] [Related]
9. Prospects for immunisation against Marburg and Ebola viruses.
Geisbert TW; Bausch DG; Feldmann H
Rev Med Virol; 2010 Nov; 20(6):344-57. PubMed ID: 20658513
[TBL] [Abstract][Full Text] [Related]
10. Progress in filovirus vaccine development: evaluating the potential for clinical use.
Falzarano D; Geisbert TW; Feldmann H
Expert Rev Vaccines; 2011 Jan; 10(1):63-77. PubMed ID: 21162622
[TBL] [Abstract][Full Text] [Related]
11. Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection.
To A; Wong TAS; Ball AH; Lieberman MM; Yalley-Ogunro J; Cabus M; Nezami S; Paz F; Elyard HA; Borisevich V; Agans KN; Deer DJ; Woolsey C; Cross RW; Geisbert TW; Donini O; Lehrer AT
Vaccine; 2024 Jan; 42(3):598-607. PubMed ID: 38158300
[TBL] [Abstract][Full Text] [Related]
12. A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus.
Woolsey C; Borisevich V; Agans KN; O'Toole R; Fenton KA; Harrison MB; Prasad AN; Deer DJ; Gerardi C; Morrison N; Cross RW; Eldridge JH; Matassov D; Geisbert TW
J Infect Dis; 2023 Nov; 228(Suppl 7):S660-S670. PubMed ID: 37171813
[TBL] [Abstract][Full Text] [Related]
13. Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector.
Pratt WD; Wang D; Nichols DK; Luo M; Woraratanadharm J; Dye JM; Holman DH; Dong JY
Clin Vaccine Immunol; 2010 Apr; 17(4):572-81. PubMed ID: 20181765
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses.
Willet M; Kurup D; Papaneri A; Wirblich C; Hooper JW; Kwilas SA; Keshwara R; Hudacek A; Beilfuss S; Rudolph G; Pommerening E; Vos A; Neubert A; Jahrling P; Blaney JE; Johnson RF; Schnell MJ
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S414-24. PubMed ID: 26063224
[TBL] [Abstract][Full Text] [Related]
15. Serological evidence of Ebola virus infection in Indonesian orangutans.
Nidom CA; Nakayama E; Nidom RV; Alamudi MY; Daulay S; Dharmayanti IN; Dachlan YP; Amin M; Igarashi M; Miyamoto H; Yoshida R; Takada A
PLoS One; 2012; 7(7):e40740. PubMed ID: 22815803
[TBL] [Abstract][Full Text] [Related]
16. Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVΔG-ZEBOV-GP).
Raabe V; Lai L; Morales J; Xu Y; Rouphael N; Davey RT; Mulligan MJ
Vaccine; 2023 Feb; 41(8):1513-1523. PubMed ID: 36725433
[TBL] [Abstract][Full Text] [Related]
17. A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model.
Keshwara R; Hagen KR; Abreu-Mota T; Papaneri AB; Liu D; Wirblich C; Johnson RF; Schnell MJ
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567978
[TBL] [Abstract][Full Text] [Related]
18. A Recombinant Vesicular Stomatitis Virus-Based Vaccine Provides Postexposure Protection Against Bundibugyo Ebolavirus Infection.
Woolsey C; Strampe J; Fenton KA; Agans KN; Martinez J; Borisevich V; Dobias NS; Deer DJ; Geisbert JB; Cross RW; Connor JH; Geisbert TW
J Infect Dis; 2023 Nov; 228(Suppl 7):S712-S720. PubMed ID: 37290053
[TBL] [Abstract][Full Text] [Related]
19. Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates.
Woolsey C; Geisbert JB; Matassov D; Agans KN; Borisevich V; Cross RW; Deer DJ; Fenton KA; Eldridge JH; Mire CE; Geisbert TW
J Infect Dis; 2018 Nov; 218(suppl_5):S582-S587. PubMed ID: 29939296
[TBL] [Abstract][Full Text] [Related]
20. Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates.
Wong G; Richardson JS; Pillet S; Patel A; Qiu X; Alimonti J; Hogan J; Zhang Y; Takada A; Feldmann H; Kobinger GP
Sci Transl Med; 2012 Oct; 4(158):158ra146. PubMed ID: 23115355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
